Treatment_of_uterine_leiomyomata_with_a_luteinizing_hormone-releasing_hormone_agonist:_the_possibility_of_nonsurgical_management_in_selected_perimenopausal_women._OBJECTIVE:_To_evaluate_the_efficacy_of_luteinizing_hormone-releasing_hormone_agonist_(LH-RH-a)_in_the_treatment_of_leiomyomata._DESIGN:_A_retrospective_randomized_trial._SETTING:_Hospital_department_of_obstetrics_and_gynecology._PATIENTS:_Twenty-five_women,_ages_36_to_54_years_with_symptomatic_uterine_leiomyomata,_were_divided_into_two_groups_according_to_the_responsiveness_to_LH-RH-a:_group_A_patients_reached_menopause_after_LH-RH-a,_whereas_resumption_of_menstruation_occurred_within_12_weeks_after_cessation_of_therapy_in_group_B._INTERVENTIONS:_Luteinizing_hormone-releasing_hormone_agonist_was_administered_intranasally_three_times_a_day_with_150_micrograms_insufflation_of_one_spray_in_each_nostril_(total_dose:_900_micrograms/d)._MAIN_OUTCOME_MEASURES:_Efficacies_of_treatment_were_assessed_in_terms_of_uterine_volume,_hemoglobin_concentrations,_serum_levels_of_luteinizing_hormone_(LH),_follicle-stimulating_hormone_(FSH),_estradiol_(E2),_and_bone_density_during_and_after_treatment._RESULTS:_In_both_groups,_hemoglobin_concentrations_increased_significantly_after_16_weeks_of_treatment._A_significant_reduction_in_uterine_volume_was_observed_in_both_groups._After_completing_therapy,_there_was_no_further_significant_change_in_uterine_volume_in_group_A,_whereas_uterine_volume_in_group_B_returned_to_pretreatment_values._Serum_LH_and_FSH_concentrations_were_suppressed_during_treatment,_but_those_gonadotropins_in_group_A_increased_significantly_up_to_the_menopausal_levels_after_treatment._Serum_E2_concentrations_in_both_groups_showed_consistent_suppression_by_the_end_of_the_first_treatment_cycle._After_cessation_of_therapy,_serum_E2_levels_on_group_A_remained_in_the_castrate_range,_whereas_E2_in_group_B_returned_to_pretreatment_levels,_concomitant_with_the_return_of_normal_ovulation._CONCLUSIONS:_Intranasal_administration_of_LH-RH-a_was_successful_in_significantly_decreasing_uterine_volume_and_increasing_hemoglobin_concentration_in_premenopausal_women_with_leiomyomata.